Abstract:Cardiovascular diseases (CVDs) present a significant threat to health, with traditional therapeutics based treatment being hindered by inefficiencies, limited biological effects, and resistance to conventional drug. Addressing these challenges requires advanced approaches for early disease diagnosis and therapy. Nanotechnology and nanomedicine have emerged as promising avenues for personalized CVD diagnosis and treatment through theranostic agents. Nanoparticles serve as nanodevices or nanocarriers, efficiently transporting drugs to injury sites. These nanocarriers offer the potential for precise drug and gene delivery, overcoming issues like bioavailability and solubility. By attaching specific target molecules to nanoparticle surfaces, controlled drug release to targeted areas becomes feasible. In the field of cardiology, nanoplatforms have gained popularity due to their attributes, such as passive or active targeting of cardiac tissues, enhanced sensitivity and specificity, and easy penetration into heart and artery tissues due to their small size. However, concerns persist about the immunogenicity and cytotoxicity of nanomaterials, necessitating careful consideration. Nanoparticles also hold promise for CVD diagnosis and imaging, enabling straightforward diagnostic procedures and real-time tracking during therapy. Nanotechnology has revolutionized cardiovascular imaging, yielding multimodal and multifunctional vehicles that outperform traditional methods. The paper provides an overview of nanomaterial delivery routes, targeting techniques, and recent advances in treating, diagnosing, and engineering tissues for CVDs. It also discusses the future potential of nanomaterials in CVDs, including theranostics, aiming to enhance cardiovascular treatment in clinical practice. Ultimately, refining nanocarriers and delivery methods has the potential to enhance treatment effectiveness, minimize side effects, and improve patients' well-being and outcomes.

Journey into Tomorrow: Cardiovascular Wellbeing Transformed by Nano-Scale Innovations

Nanomaterial-based biosensors for measurement of lipids and lipoproteins towards point-of-care of cardiovascular disease.

Nano Revolution in Cardiovascular Health: Nanoparticles (NPs) as Tiny Titans for Diagnosis and Therapeutics

Applications of Nanotechnology in the Field of Cardiology

Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering

Nanomedicine in cardiology: Precision drug delivery for enhanced patient outcomes

Novel cutting edge nano-strategies to address old long-standing complications in cardiovascular diseases. A comprehensive review

Nano Guardians of the Heart: A Comprehensive Investigation into the Impact of Silver Nanoparticles on Cardiovascular Physiology

Recent Advancement in Nanotechnology based Drug Delivery for the Management of Cardiovascular disease.

Multifunctional Role of Nanoparticles for the Diagnosis and Therapeutics of Cardiovascular Diseases

Nanotechnology for cardiovascular diseases

Latest advances in biomimetic nanomaterials for diagnosis and treatment of cardiovascular disease

Cardiovascular Nanotechnology

Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities

Recent Advances of Cell Membrane Coated Nanoparticles in Treating Cardiovascular Disorders

Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective

Regenerative Medicine and Nanotechnology approaches against Cardiovascular Diseases: Recent Advances and Future Prospective

New insights to atherosclerosis management: Role of nanomaterials

Nanomedicine Approaches for Advanced Diagnosis and Treatment of Atherosclerosis and Related Ischemic Diseases

A Cross-talk between Nanomedicines and Cardiac Complications: Comprehensive View